Thymidine phosphorylase activity in liver tissue and its correlation with multifocal occurrence of hepatocellular carcinomas

In Vivo

Volumn 15, Issue 4, 2001, Pages 265-270

  Ikeguchi, M ^a   Sakatani, T ^a   Ueda, T ^a   Hirooka, Y ^a   Kaibara, N ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; THYMIDINE PHOSPHORYLASE;

ANGIOGENESIS; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; PROGNOSIS; RECURRENCE RISK; RISK FACTOR; TISSUE LEVEL;

EID: 0034755070     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment
2. Assessment of the biological malignancy of hepatocellular carcinoma: Relationship to clinicopathological factors and prognosis
3. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan
4. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival
5. Role of angiogenesis in hepatitis and hepatocellular carcinoma. Hepatocellular carcinoma
6. Microvessel density of hepatocellular carcinoma: Its relationship with prognosis
7. Arterial elements and perisinusoidal cells in borderline hepatocellular nodules and small hepatocellular carcinomas
8. Angiogenic factor
9. Protein measurement with the Folin phenol reagent
10. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detectingthe enzyme levels in tumor tissues
11. Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by Taxol/Taxotere in human cancer xenografts
12. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts
13. Immunohistochemical identification of factor VIII-related antigen in endothelial cells of cutaneous lesions of alleged vascular nature
14. Tumor angiogenesis in primary and metastatic colorectal cancers
15. Independent prognostic importance of microvessel density in endometrial carcinoma
16. The expression of thymidine phosphorylase and its correlation with angiogenesis in gastric adenocarcinoma
17. Loss of the tumor suppressor p53 gene at the liver cirrhosis stage in Japanese patients with hepatocellular carcinoma
18. Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation
19. Relationship between loss of heterozygosity of tumor suppressor genes and histologic diffentiation in hepatocellular carcinoma
20. What is the evidence that tumors are angiogenically dependent?
21. Novel growth regulatory factors and tumor angionenesis
22. Kinetic studies of thymidine phosphorylase from mouse liver
23. Angiogenic activity of enzyme
24. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase
25. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis
26. Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells
27. The significance of thymidine phosphorylase activity in hepatocellular carcinoma and chronic diseased livers: A special reference to liver fibrosis and multicentric tumor occurrence
28. Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma
29. Expression and localization of vascular endothelial growth factor receptors in human heptocellular carcinoma and non-HCC tissues